Chronic Myeloid Leukemia: Clinical Trials

8 trials for Chronic Myeloid Leukemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 terminated, 2 unknown. 8 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 48Completed 4, Terminated 2, Unknown 2

Follow Chronic Myeloid Leukemia: new trials by email Literature Review of Chronic Myeloid Leukemia trials Research Report on Chronic Myeloid Leukemia

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dose Reduced Dasatinib (70 mg Daily) as First-line Treatment for Newly Diagnosed CML-CP
Dasatinib - Dasatinib, BCR-ABL
Phase 4UnknownShenzhen Second People's Hospital652019-12-012022-07-27
Study Assessing Deep Molecular Response in Adult Patients With CML in Chronic Phase Treated With Nilotinib Firstline.
Nilotinib - Chronic Myeloid Leukemia
Phase 4CompletedNovartis Pharmaceuticals1712016-02-182022-07-22
Efficacy and Safety of Imatinib Mesylate as First-line Treatment for the Patients With Chronic Phase of Chronic Myeloid Leukemia
Imatinib - Chronic Myeloid Leukemia
Phase 4UnknownCttq902015-02-012014-12-15
A Study to Evaluate Efficacy and Safety of Glinib in Newly Diagnosed CML Patients
600mg/day of Imatinib, 400mg/day of Imatinib - Chronic Myeloid Leukemia
Phase 4TerminatedDong-A ST Co., Ltd.552014-10-132018-06-15
Validation of Digital-PCR Analysis Through Programmed Imatinib Interruption in PCR Negative CML Patients
Imatinib mesylate - Chronic Myeloid Leukemia
Phase 4CompletedUniversity of Milano Bicocca1122011-11-092019-12-03
Study of Treatment With Nilotinib in Adult Patients With Imatinib - Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase
Nilotinib - Chronic Myeloid Leukemia
Phase 4CompletedNovartis Pharmaceuticals892008-08-012017-02-23
Chromosome Abnormalities in Chronic Myeloid Leukemia (CML) on Imatinib. GIST Patients on Imatinib
bone marrow aspiration - Chronic Myeloid Leukemia, Gastrointestinal Stromal Cell Tumors
Phase 4TerminatedUniversity Health Network, Toronto682005-02-012009-02-13
Glivec in Pediatric Chronic Myeloid Leukemia (CML)
Imatinib mesylate 100 mg (Glivec) - Chronic Myeloid Leukemia
Phase 4CompletedPoitiers University Hospital442004-07-012016-10-11

Narrower conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive (8)  ·  Chromosome Aberrations (1)  ·  Leukemia (1)

Broader conditions

Bone Marrow Diseases (8)  ·  Chronic Disease (8)  ·  Disease Attributes (8)  ·  Hematologic Diseases (8)  ·  Hemic and Lymphatic Diseases (8)  ·  Leukemia, Myeloid (8)  ·  Myeloproliferative Disorders (8)  ·  Neoplasms (8)  ·  Neoplasms by Histologic Type (8)  ·  Pathologic Processes (8)  ·  Pathological Conditions, Signs and Symptoms (8)  ·  Leukemia (7)

Interventions

Imatinib Mesylate (4)  ·  nilotinib (2)  ·  Dasatinib (1)

Sponsors

Novartis Pharmaceuticals (2)  ·  Cttq (1)  ·  Dong-A ST Co., Ltd. (1)  ·  Poitiers University Hospital (1)  ·  Shenzhen Second People's Hospital (1)  ·  University Health Network, Toronto (1)  ·  University of Milano Bicocca (1)

Countries

Canada (2)  ·  Germany (2)  ·  Brazil (1)  ·  China (1)  ·  France (1)  ·  Israel (1)  ·  Italy (1)  ·  South Korea (1)  ·  Spain (1)

Top investigators

Alessandra Iurlo, MD (1)  ·  Arnon Nagler, MD (1)  ·  Bruno Martino, MD (1)  ·  Carlo Gambacorti-Passerini, MD (1)  ·  Chul-won Choi, M.D. (1)  ·  Chul-won Jung, M.D. (1)  ·  Duk-yeon Cho, M.D. (1)  ·  Elisabetta Abruzzese, MD (1)  ·  Eros Di Bona, MD (1)  ·  Ester Pungolino, MD (1)  ·  Francesco Di Raimondo, MD (1)  ·  Jeff Lipton, MD (1)  ·  Jin-hee Park, M.D. (1)  ·  Joo-sup Joeng, M.D. (1)

Results publications

PMID 21670449, PMID 25170123

NIH funding

2015 (1)